272 completed, 78 withdrawn, 69 terminated, 48 recruiting. 185 Not applicable, 149 Phase 2, 80 Phase 1, 26 Early Phase 1, 12 Phase 3.
Follow Case Comprehensive Cancer Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2027-01-01 | 2026-08-05 |
| Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer Sentinel node biopsy with blue dye and radioisotope - Breast Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2027-01-01 | 2026-10-21 |
| Culinary And Lifestyle Medicine Education for Cancer Risk Reduction in Survivors of Breast Cancer Living Cancer CALM education intervention - Breast Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 44 | 2026-11-16 | 2026-10-30 |
| Wearable-Triggered Digital Safety Net for Real-Time Monitoring & Intervention in Leptomeningeal Metastasis Calibration Phase, Stepped Wedge Intervention Phase - Leptomeningeal Metastasis | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 48 | 2026-11-01 | 2026-09-03 |
| Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) Intestinal, Multivisceral or Modified Multivisceral Transplantation, Alemtuzumab, Tacrolimus - Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum | Phase 2 | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2026-11-01 | 2026-09-24 |
| High-concentration Capsaicin Patch for the Prevention of Paclitaxel-induced Peripheral Neuropathy High Concentration Capsaicin Patch (HCCP), Placebo patch - Chemotherapy-induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy | Phase 4 | Not yet recruiting | Case Comprehensive Cancer Center | 240 | 2026-10-01 | 2026-09-22 |
| Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS) Peristeen Plus Irrigation kit, LARS mobile application - Colorectal Cancer, Low Anterior Resection Syndrome | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 60 | 2026-10-01 | 2026-08-18 |
| Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations No intervention - Breast Cancer, Breast Cancer Stage I | Not yet recruiting | Case Comprehensive Cancer Center | 240 | 2026-10-01 | 2026-08-28 | |
| Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial) RAB via the Monarch platform, RAB via the ION platform - Lung; Node | Not applicable | Recruiting | Case Comprehensive Cancer Center | 398 | 2026-10-01 | 2026-10-21 |
| Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade Glioma Disulfiram (DSF) - Brain (Nervous System) Cancers | Phase 1 | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2026-10-01 | 2026-10-27 |
| Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors Specimen #1, Specimen #2 - Marker; Structural | Recruiting | Case Comprehensive Cancer Center | 120 | 2026-09-01 | 2026-08-26 | |
| Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy Neoadjuvant Chemotherapy, Partial cystectomy with Extended pelvic lymph node dissection, Adjuvant systemic therapy - Malignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma | Phase 2 | Withdrawn | Case Comprehensive Cancer Center | 2026-09-01 | 2026-09-24 | |
| Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy Donor Radical and Partial Nephrectomy, Kidney Transplantation, Laparoscopic Radical Nephrectomy - Renal Cell Carcinoma | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 5 | 2026-09-01 | 2026-08-06 |
| A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment MiraBurst - Dysgeusia, Solid Tumor | Not applicable | Recruiting | Case Comprehensive Cancer Center | 45 | 2026-09-01 | 2026-10-28 |
| Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) MINDSET, Enhanced Usual Care (EUC) - Depression, Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 76 | 2026-08-03 | 2026-01-23 |
| Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis BCMA bispecific - Amyloid Light-chain Amyloidosis | Phase 2 | Not yet recruiting | Case Comprehensive Cancer Center | 64 | 2026-08-01 | 2026-08-05 |
| Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) MA-WBRT (Memory Avoidance Whole Brain Radiation Therapy (MA-WBRT)), HA-WBRT (Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT)), Memantine - Brain Metastases | Phase 2 | Recruiting | Case Comprehensive Cancer Center | 90 | 2026-07-09 | 2026-09-22 |
| Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials Wearable actigraphy, Electronic Patient-Reported Outcomes (ePROs) - Cancer | Not applicable | Recruiting | Case Comprehensive Cancer Center | 30 | 2026-07-08 | 2026-08-04 |
| Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma Standard of care chemotherapy, LNSC - Esophageal Adenocarcinoma, Esophageal Cancer | Phase 2 | Recruiting | Case Comprehensive Cancer Center | 40 | 2026-06-10 | 2026-08-18 |
| Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients Axillary Lymph Node Dissection, Axillary Reverse Mapping, Lymphaticovenous Bypass - Node-positive Breast Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 400 | 2026-06-01 | 2026-02-19 |
Showing 20 of 498. Sign in to see all of them.
Breast Neoplasms (71) · Prostatic Neoplasms (45) · Neoplasms (38) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (32) · Lymphoma, Non-Hodgkin (30) · Brain Neoplasms (29) · Lymphoma, Large B-Cell, Diffuse (28) · Leukemia, Myeloid, Acute (27) · Lymphoma (27) · Lung Neoplasms (26) · Lymphoma, Follicular (25) · Multiple Myeloma (25) · Carcinoma, Non-Small-Cell Lung (24) · Leukemia, Lymphocytic, Chronic, B-Cell (24) · Lymphoma, Mantle-Cell (24)
Cyclophosphamide (28) · Radiotherapy (28) · Radiosurgery (19) · Docetaxel (16) · Filgrastim (15) · Etoposide (14) · Surveys and Questionnaires (14) · Bevacizumab (13) · Carboplatin (13) · Doxorubicin (13) · Paclitaxel (13) · Cisplatin (12) · fludarabine phosphate (12) · Immunohistochemistry (11) · Busulfan (10)
United States (458) · Kenya (1) · Uganda (1)
Scot C. Remick, MD (14) · Afshin Dowlati, MD (12) · David Peereboom, MD (8) · Brenda W. Cooper, MD (6) · Nathan Levitan, MD (6) · Panayiotis Savvides, MD (6) · Smitha Krishnamurthi, MD (5) · Beth A. Overmoyer, MD, FACP (4) · Brenda Cooper, MD (4) · David J. Adelstein, MD (4) · Hillard M. Lazarus, MD (4) · Janice Lyons, MD (4) · Jennifer Eads, MD (4) · Jorge Garcia, MD (4) · Monica Webb Hooper, PhD (4)
PMID 21173649, PMID 25532471, PMID 34604088, PMID 37816266, PMID 11986207, PMID 12231519, PMID 17513814, PMID 17910637, PMID 18316792, PMID 18414865, PMID 18470481, PMID 18769450, PMID 19011760, PMID 19243603, PMID 19265494, PMID 19286996, PMID 19399502, PMID 19509175, PMID 22002488, PMID 22425095, PMID 22445005, PMID 23523362, PMID 23553066, PMID 24028306, PMID 24332215, PMID 24954745, PMID 25015089, PMID 25621498, PMID 26700120, PMID 26700123, PMID 29321008, PMID 30191523, PMID 30402678, PMID 30782111, PMID 31097024, PMID 31231785, PMID 31371315, PMID 31427205, PMID 31478164, PMID 31600167, PMID 32205788, PMID 32349020, PMID 33434451, PMID 33539554, PMID 33816283, PMID 34033228, PMID 34081125, PMID 34107914, PMID 34647777, PMID 34900741
P30CA043703 (154), U01CA062502 (11), U01CA063200 (4), P50CA150964 (2), K12CA076917 (1), P01CA084203 (1), R01CA127655 (1), R01CA196687 (1), R21CA076192 (1), R21ES036031 (1), R37CA240707 (1), R44CA250727 (1), R44HL145948 (1), T32AR007569 (1), U01CA257638 (1)